These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20075175)

  • 1. Acid sphingomyelinase deficiency does not protect from graft-versus-host disease in transplant recipients with Niemann-Pick disease.
    Tolar J; Eapen M; Orchard PJ; Blazar BR
    Blood; 2010 Jan; 115(2):434-5. PubMed ID: 20075175
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytolytic T cells induce ceramide-rich platforms in target cell membranes to initiate graft-versus-host disease.
    Rotolo JA; Stancevic B; Lu SX; Zhang J; Suh D; King CG; Kappel LW; Murphy GF; Liu C; Fuks Z; van den Brink MR; Kolesnick R
    Blood; 2009 Oct; 114(17):3693-706. PubMed ID: 19666872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas-deficient lpr mice are more susceptible to graft-versus-host disease.
    van Den Brink MR; Moore E; Horndasch KJ; Crawford JM; Hoffman J; Murphy GF; Burakoff SJ
    J Immunol; 2000 Jan; 164(1):469-80. PubMed ID: 10605044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APCs in the liver and spleen recruit activated allogeneic CD8+ T cells to elicit hepatic graft-versus-host disease.
    Zhang Y; Shlomchik WD; Joe G; Louboutin JP; Zhu J; Rivera A; Giannola D; Emerson SG
    J Immunol; 2002 Dec; 169(12):7111-8. PubMed ID: 12471148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Graft-versus-host disease causes failure of donor hematopoiesis and lymphopoiesis in interferon-gamma receptor-deficient hosts.
    Delisle JS; Gaboury L; Bélanger MP; Tassé E; Yagita H; Perreault C
    Blood; 2008 Sep; 112(5):2111-9. PubMed ID: 18552211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allospecific CD8+ Tc1 and Tc2 populations in graft-versus-leukemia effect and graft-versus-host disease.
    Fowler DH; Breglio J; Nagel G; Eckhaus MA; Gress RE
    J Immunol; 1996 Dec; 157(11):4811-21. PubMed ID: 8943383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
    Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
    Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-mediated liver damage in MRL hemopoietic chimeras undergoing lpr-mediated graft-versus-host disease.
    Bobé P; Bonardelle D; Reynès M; Godeau F; Mahiou J; Joulin V; Kiger N
    J Immunol; 1997 Nov; 159(9):4197-204. PubMed ID: 9379013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PI3Kγ controls leukocyte recruitment, tissue injury, and lethality in a model of graft-versus-host disease in mice.
    Castor MG; Rezende BM; Bernardes PT; Vieira AT; Vieira EL; Arantes RM; Souza DG; Silva TA; Teixeira MM; Pinho V
    J Leukoc Biol; 2011 Jun; 89(6):955-64. PubMed ID: 21402770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic analysis of donor cells infiltrating the small intestinal epithelium and spleen during graft-versus-host disease.
    Schattenfroh NC; Hoffman RA; McCarthy SA; Simmons RL
    Transplantation; 1995 Jan; 59(2):268-73. PubMed ID: 7839451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory arthropathy in MRL hematopoietic chimeras undergoing Fas mediated graft-versus-host syndrome.
    Bonardelle D; Bobé P; Reynès M; Amouroux J; Tricottet V; Godeau F; Kiger N
    J Rheumatol; 2001 May; 28(5):956-61. PubMed ID: 11361222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Niemann-Pick Disease versus acid sphingomyelinase deficiency.
    Lozano J; Morales A; Cremesti A; Fuks Z; Tilly JL; Schuchman E; Gulbins E; Kolesnick R
    Cell Death Differ; 2001 Jan; 8(1):100-3. PubMed ID: 11313707
    [No Abstract]   [Full Text] [Related]  

  • 13. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease.
    Zeng D; Lewis D; Dejbakhsh-Jones S; Lan F; García-Ojeda M; Sibley R; Strober S
    J Exp Med; 1999 Apr; 189(7):1073-81. PubMed ID: 10190898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived IL-15 is critical for acute allogeneic graft-versus-host disease.
    Blaser BW; Roychowdhury S; Kim DJ; Schwind NR; Bhatt D; Yuan W; Kusewitt DF; Ferketich AK; Caligiuri MA; Guimond M
    Blood; 2005 Jan; 105(2):894-901. PubMed ID: 15374888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model.
    Dey B; Yang YG; Preffer F; Shimizu A; Swenson K; Dombkowski D; Sykes M
    Transplantation; 1999 Jul; 68(1):141-9. PubMed ID: 10428282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Kwon BS; Panoskaltsis-Mortari A; Kwak KB; Peschon JJ; Taylor PA
    J Immunol; 2001 Mar; 166(5):3174-83. PubMed ID: 11207270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression.
    Whitaker-Menezes D; Jones SC; Friedman TM; Korngold R; Murphy GF
    Biol Blood Marrow Transplant; 2003 Sep; 9(9):559-70. PubMed ID: 14506658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR; Majewski D; Ozker K; Hanson G
    J Immunol; 1998 Sep; 161(5):2610-9. PubMed ID: 9725263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.